University Medical Center Groningen

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1614-01-01

Employees: 10K

Market Cap: -

Website: https://www.umcg.nl

Clinical Trials

Detection of Early Esophageal Cancer by NIR-FME.

Phase 2

Conditions: Barrett Esophagus

Interventions: Drug: Bevacizumab-IRDye800CW
Diagnostic Test: Fluorescence endoscopy

First Posted Date: 2019-03-15

Last Posted Date: 2020-11-04

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 60

Registration Number: NCT03877601

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients

Not Applicable

Withdrawn

Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Interventions: Other: 89Zr-atezolizumab PET scans

First Posted Date: 2019-02-21

Last Posted Date: 2023-05-15

Lead Sponsor: University Medical Center Groningen

Registration Number: NCT03850028

Locations: 🇳🇱
VU University Medical Center, Amsterdam, Noord-Holland, Netherlands
🇳🇱
University Medical Center Groningen, Groningen, Netherlands

Development of an Effective Home-based-exercise-strategy

Not Applicable

Completed

Conditions: Total Hip Arthroplasty
Osteoarthritis, Hip

Interventions: Other: Home-based rehabilitation program

First Posted Date: 2019-02-19

Last Posted Date: 2024-04-18

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 30

Registration Number: NCT03846063

Influence of PESF on Oxygen Saturation, Quality of Life and Exercise Capacity in COPD

Not Applicable

Terminated

Conditions: COPD

Interventions: Device: Pulsating Electrostatic Field
Device: SHAM Pulsating Electrostatic Field

First Posted Date: 2019-01-09

Last Posted Date: 2024-01-19

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 10

Registration Number: NCT03797794

Locations: 🇳🇱
Tjongerschans, Heerenveen, Friesland, Netherlands

RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients

Phase 4

Active, not recruiting

Conditions: Renal Transplant Recipients
Elderly Patients
Immunosuppression

Interventions: Drug: standard dose tacrolimus with mycophenolate mofetil
Drug: low dose tacrolimus in combination with everolimus

First Posted Date: 2019-01-09

Last Posted Date: 2023-05-10

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 374

Registration Number: NCT03797196

Locations: 🇳🇱
LUMC, Leiden, Netherlands
🇳🇱
UMCU, Utrecht, Netherlands
🇧🇪
Leuven University Hospital, Leuven, Belgium

and more 4 locations

Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

Phase 4

Active, not recruiting

Conditions: Heart Failure

Interventions: Drug: Digoxin
Drug: Placebos

First Posted Date: 2018-12-21

Last Posted Date: 2023-12-12

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 982

Registration Number: NCT03783429

Locations: 🇳🇱
Gelre Ziekenhuizen, Apeldoorn, Netherlands
🇳🇱
Ziekenhuis Gelderse Vallei, Ede, Netherlands
🇳🇱
Groene Hart Ziekenhuis, Gouda, Netherlands

and more 41 locations

Risk Prediction of Venous Thromboembolism in Critically Ill

Conditions: Critical Illness
Venous Thrombosis

First Posted Date: 2018-12-12

Last Posted Date: 2019-01-15

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 5400

Registration Number: NCT03773939

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

The Influence of Cognitive Decline on Quality of Life After Coronary Bypass

Conditions: Coronary Artery Bypass
Cognitive Dysfunction

Interventions: Procedure: Coronary Artery Bypass Grafting

First Posted Date: 2018-12-12

Last Posted Date: 2019-01-11

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 140

Registration Number: NCT03774342

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation

Phase 3

Completed

Conditions: Iron-deficiency
Transplant-Related Disorder

Interventions: Drug: Ferric carboxymaltose
Drug: Sodium chloride

First Posted Date: 2018-12-07

Last Posted Date: 2024-08-27

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 148

Registration Number: NCT03769441

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇳🇱
University Medical Center Utrecht, Utrecht, Netherlands

Fasting Tolerance in MCADD-infants

Not Applicable

Conditions: Mcad Deficiency

Interventions: Other: Fasting test

First Posted Date: 2018-12-03

Last Posted Date: 2019-05-14

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 20

Registration Number: NCT03761693

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy